Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2005
03/15/2005CA2174954C Chimeric regulatory regions and gene cassettes for expression of genes in plants
03/15/2005CA2170034C Recombinant humanized anti-human immunodeficiency virus antibody
03/15/2005CA2054325C Antisense oligonucleotides for treatment of cancer
03/15/2005CA1341476C Moleculary cloned acquired immunodeficiency syndrome polypeptides and their methods of use
03/10/2005WO2005022167A2 Compounds that act to modulate insect growth and methods and systems for identifying such compounds
03/10/2005WO2005021791A1 Method of evaluating effect of external stimulus by using vital cells, kit for performing the method and system of evaluating effect on external stimulus
03/10/2005WO2005021785A1 Standards in pcr
03/10/2005WO2005021784A2 Estimation of activity or inhibition of processes involved in nucleic acid modification using chemiluminescence quenching
03/10/2005WO2005021777A2 Uses of spatial configuration to modulate protein function
03/10/2005WO2005021776A2 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF
03/10/2005WO2005021770A1 Process for producing succinic acid
03/10/2005WO2005021769A1 Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
03/10/2005WO2005021768A1 Aav vectors for in vivo gene therapy of rheumatoid arthritis
03/10/2005WO2005021767A1 Tumor-specific expression of reporter genes
03/10/2005WO2005021766A1 Regulatable gene expression in mammalian cells and mammals
03/10/2005WO2005021765A2 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins
03/10/2005WO2005021764A2 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
03/10/2005WO2005021763A2 O-methyltransferases of tetrahydrobenzylisoquinoline alkaloid biosynthesis in papaver somniferum
03/10/2005WO2005021762A2 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
03/10/2005WO2005021761A1 Fatty acid desaturases from primula
03/10/2005WO2005021760A1 Method of improving the viability and the fermentation capacity of baking yeasts under hyperosmotic stress and freezing stress conditions
03/10/2005WO2005021759A1 Plant vasculature modulating factor
03/10/2005WO2005021758A1 Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist
03/10/2005WO2005021757A1 Polypeptides and polynucleotides for use as a medicament
03/10/2005WO2005021754A1 Gp131: methods and compositions for treating cancer
03/10/2005WO2005021753A1 Probe carrier and method for quantifying target substance using the probe carrier
03/10/2005WO2005021752A1 Method of searching for functional nucleotide molecule
03/10/2005WO2005021750A1 Treatment of menorrhagia, dysmenorrhoea or endometriosis
03/10/2005WO2005021749A1 Interfering rna duplex having blunt-ends and 3’-modifications
03/10/2005WO2005021748A1 Method for magnetic bead isolation of nucleic acids
03/10/2005WO2005021747A1 Novel vector and utilization of the same
03/10/2005WO2005021746A1 Recombinant virus vector originating in hhv-6 or hhv-7, method of producing the same, method of transforming host cell using the same, host cell transformed thereby and gene therapy method using the same
03/10/2005WO2005021745A1 Hepatocellular cancer-associated gene
03/10/2005WO2005021744A1 Digital cell
03/10/2005WO2005021740A1 Method for detoxification of mycotoxins
03/10/2005WO2005021739A1 ANTIBODY AGAINST Nox1 POLYPEPTIDE, METHOD OF DIAGNOSING CANCER WITH THE USE OF Nox1 GENE AND METHOD OF SCREENING CANCER GROWTH INHIBITOR
03/10/2005WO2005021733A2 Methods and compositions for sirna expression
03/10/2005WO2005021723A2 Nucleic acid molecules from rice controlling abiotic stress tolerance
03/10/2005WO2005021722A2 METHODS AND COMPOSITIONS FOR INHIBITION OF NUCLEAR FACTOR κB
03/10/2005WO2005021719A2 Libraries of recombinant chimeric proteins
03/10/2005WO2005021718A2 Tubulin regulatory elements for use in plants
03/10/2005WO2005021714A2 Laccases, nucleic acids encoding them and methods for making and using them
03/10/2005WO2005021705A2 Citrus sesquiterpene synthase, methods of production and uses thereof
03/10/2005WO2005021595A1 Methods of antibody engineering using antibody display rules
03/10/2005WO2005021590A1 Promoter of the human fatp5 gene and uses
03/10/2005WO2005021588A1 Gastric and prostate cancer associated antigens
03/10/2005WO2005021587A1 Novel storage protein - encoding gene and uses therefor
03/10/2005WO2005021586A2 Metabolic engineering of viomycin biosynthesis
03/10/2005WO2005021585A2 Axmi-003, a delta-endotoxin gene and methods for its use
03/10/2005WO2005021583A2 METHODS FOR IDENTIFYING, TREATING, AND INDUCING INFERTILITY USING SMC1β
03/10/2005WO2005021581A2 Inducers of plant disease resistance
03/10/2005WO2005021577A2 Novel plant glycine and histidinie-rich metal-binding protein family and uses thereof
03/10/2005WO2005021572A1 Ptp1b antisense compound
03/10/2005WO2005021570A1 Novel artificial nucleic acids of n-o bond crosslinkage type
03/10/2005WO2005021564A1 Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof
03/10/2005WO2005021557A2 Poly-pegylated protease inhibitors
03/10/2005WO2005021514A1 Novel unnatural histidine analog amino acid
03/10/2005WO2005021044A2 Nanoparticles for delivery of nucleic acids and stable double-stranded rna
03/10/2005WO2005021035A1 A bivalent vaccine against fmd, its preparation methods and applications
03/10/2005WO2005021025A2 MODULATION OF β-CATENIN/TCF ACTIVATED TRANSCRIPTION
03/10/2005WO2005020972A2 Combination therapy for the treatment of ocular neovascular disorders
03/10/2005WO2005020916A2 Myoblast treatment of diseased or weakened organs
03/10/2005WO2005020888A2 Compositions and methods of treating and diagnosing hepatoma
03/10/2005WO2005020683A1 Chimeric cancer models
03/10/2005WO2005020682A1 Transgenic mouse having lean phenotype
03/10/2005WO2005020681A1 Transgenic animal showing aging-related diseases associating with oxidation stress
03/10/2005WO2005020680A1 Transgenic animal model for the development of novel therapeutic approaches
03/10/2005WO2005020673A1 Rice plants having increased tolerance to imidazolinone herbicides
03/10/2005WO2005007823A3 Compositions, kits, and methods for stimulation of homologous recombination
03/10/2005WO2005003389A3 In vitro amplification of dna
03/10/2005WO2005003162A3 An endogenous peptide and active subfragments thereof
03/10/2005WO2005000355A8 Treatment of tumor by cotransferring chemotherapeutic agent with cytokine gene
03/10/2005WO2004104033A3 Viruses dependent on inducing agents for viral entry into a host cell
03/10/2005WO2004099404A3 Bioinformatic method for predicting functional equivalence between biological sequences
03/10/2005WO2004098497A3 Cd4+ human papillomavirus (hpv) epitopes
03/10/2005WO2004092348A3 Method for production of oncolytic adenoviruses
03/10/2005WO2004085654A3 Modulation of cell phenotype by inhibitory rna
03/10/2005WO2004081040A3 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications
03/10/2005WO2004078907A3 Streptococcus pyogenes antigens
03/10/2005WO2004072244A9 Polymerase-based protocols for generating chimeric oligonucleotides
03/10/2005WO2004070351A3 Protein fragment complementation assays for high-throughput and high-content screening
03/10/2005WO2004063333A3 Seed-oil suppression to enhance yield of commercially important macromolecules
03/10/2005WO2004058808A3 Dna vaccines against hantavirus infections
03/10/2005WO2004057017A3 Detection of small nucleic acids
03/10/2005WO2004056971A3 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers
03/10/2005WO2004055161A3 Large scale production of packaged alphavirus replicons
03/10/2005WO2004050674A3 Methods and materials for modulating trpm2
03/10/2005WO2004046313A3 Methods and compositions for determining methylation profiles
03/10/2005WO2004020621A8 Thermostable ribonuclease h
03/10/2005WO2004016732A3 Astrocyte modulated genes and uses thereof
03/10/2005WO2004009814A8 Gene shuffling by template switching
03/10/2005WO2004003166A3 Antibodies and uses thereof
03/10/2005WO2003103475A3 Prevention and reduction of blood loss
03/10/2005WO2003093409A3 Promoters exhibiting endothelial cell specificity and methods of using same
03/10/2005WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
03/10/2005WO2003085082A3 Nucleic acid reactions using labels with different redox potentials
03/10/2005WO2003080647A3 Homogentisate prenyl transferase ('hpt') nucleic acids and polypeptides, and uses thereof
03/10/2005WO2003076570A3 Antigens and their use as diagnostics and vaccines against species of plasmodium
03/10/2005WO2003073990A3 Treatment for asthma or allergies
03/10/2005WO2003073062A3 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
1 ... 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 ... 4023